Market capitalization | AUD13.16b |
Enterprise Value | AUD17.19b |
P/E (TTM) P/E ratio | 25.53 |
EV/FCF (TTM) EV/FCF | 28.61 |
EV/Sales (TTM) EV/Sales | 1.98 |
P/S ratio (TTM) P/S ratio | 1.52 |
P/B ratio (TTM) P/B ratio | 1.66 |
Dividend yield | 3.87% |
Last dividend (FY24) | AUD1.06 |
As a Free StocksGuide user, you can view scores for all 6,892 stocks worldwide.
14 Analysts have issued a Sonic Healthcare forecast:
14 Analysts have issued a Sonic Healthcare forecast:
Jun '24 |
+/-
%
|
||
Revenue | 8,661 8,661 |
9%
9%
|
|
Gross Profit | 2,057 2,057 |
3%
3%
|
|
EBITDA | 1,326 1,326 |
13%
13%
|
EBIT (Operating Income) EBIT | 549 549 |
33%
33%
|
Net Profit | 511 511 |
25%
25%
|
In millions AUD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Sonic Healthcare Ltd. engages in the provision of medical diagnostics services. It operates through the following segments: Laboratory, Radiology, and Other. The Laboratory segment offers pathology and clinical services in Australia, New Zealand, the United Kingdom, the United States of America, Germany, Switzerland, Belgium, and Ireland. The Radiology segment includes diagnostic imaging services in Australia. The Other segment covers the corporate office function, medical center operations and occupation health services, and other minor operations. The company was founded on September 25, 1934 and is headquartered in Sydney, Australia.
Head office | Australia |
CEO | Colin Goldschmidt |
Employees | 43,000 |
Founded | 1934 |
Website | www.sonichealthcare.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.